BlackRock’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.9M | Buy |
8,078,428
+31,490
| +0.4% | +$300K | ﹤0.01% | 2192 |
|
|
2025
Q1 | $84.2M | Buy |
8,046,938
+97,536
| +1% | +$1.02M | ﹤0.01% | 2085 |
|
|
2024
Q4 | $187M | Buy |
7,949,402
+155,288
| +2% | +$3.66M | ﹤0.01% | 1699 |
|
|
2024
Q3 | $280M | Buy |
7,794,114
+407,126
| +6% | +$14.6M | 0.01% | 1451 |
|
|
2024
Q2 | $261M | Buy |
7,386,988
+1,996,946
| +37% | +$70.5M | 0.01% | 1435 |
|
|
2024
Q1 | $153M | Buy |
5,390,042
+1,601,360
| +42% | +$45.5M | ﹤0.01% | 1794 |
|
|
2023
Q4 | $50.4M | Buy |
3,788,682
+481,717
| +15% | +$6.41M | ﹤0.01% | 2420 |
|
|
2023
Q3 | $29.6M | Sell |
3,306,965
-15,222
| -0.5% | -$136K | ﹤0.01% | 2664 |
|
|
2023
Q2 | $37.4M | Buy |
3,322,187
+702,966
| +27% | +$7.91M | ﹤0.01% | 2612 |
|
|
2023
Q1 | $30.2M | Buy |
2,619,221
+603
| +0% | +$6.95K | ﹤0.01% | 2711 |
|
|
2022
Q4 | $30.3M | Buy |
2,618,618
+93,551
| +4% | +$1.08M | ﹤0.01% | 2758 |
|
|
2022
Q3 | $32.1M | Buy |
2,525,067
+50,569
| +2% | +$642K | ﹤0.01% | 2728 |
|
|
2022
Q2 | $17M | Buy |
2,474,498
+109,517
| +5% | +$752K | ﹤0.01% | 3105 |
|
|
2022
Q1 | $22.8M | Sell |
2,364,981
-46,416
| -2% | -$447K | ﹤0.01% | 3025 |
|
|
2021
Q4 | $28.7M | Buy |
2,411,397
+423,245
| +21% | +$5.03M | ﹤0.01% | 2987 |
|
|
2021
Q3 | $32.3M | Buy |
1,988,152
+15,944
| +0.8% | +$259K | ﹤0.01% | 2914 |
|
|
2021
Q2 | $41.5M | Buy |
1,972,208
+730,497
| +59% | +$15.4M | ﹤0.01% | 2783 |
|
|
2021
Q1 | $19.3M | Buy |
1,241,711
+205,594
| +20% | +$3.19M | ﹤0.01% | 3151 |
|
|
2020
Q4 | $21.8M | Buy |
1,036,117
+732,117
| +241% | +$15.4M | ﹤0.01% | 2899 |
|
|
2020
Q3 | $6.14M | Buy |
+304,000
| New | +$6.14M | ﹤0.01% | 3392 |
|